Showing all entries tagged with »patient«
October 12, 2022
The EU biopharmaceutical ecosystem is currently languishing in third place globally. EUCOPE’s Alexander Natz discusses how the European Commission’s most fundamental review of the pharmaceutical legislation in decades is supposed to change that but in reality, is discouraging innovation and competitiveness…. read more
November 20, 2020
Empowering EMA and ECDC, strengthening EU coordination in case of cross-border health threats EUCOPE read with great interest the European Commission’s proposals to build a European Health Union, and we agree that greater coordination across Member States is very much… read more
February 27, 2020
On Rare Diseases Day, EUCOPE is delighted to host an interview with Laurence Woollard, patient expert and rare disease advocate, to discuss with him the importance of an engaged community and the opportunities and challenges new treatments can bring. Hi… read more
November 18, 2019
Science and technology in drug development are changing at a fast pace and bring with them a lot of promises. To cope with this evolution, the regulatory environment will need to adapt if it wants to keep with its mission… read more
June 5, 2019
The first gene and cell therapies have been approved for use in Europe and many more are expected to enter European markets in the near future. These state-of-the-art techniques can revolutionise medicine as we know it. Bringing high hopes for… read more